Provide various regular medication for the inmate population at FCC oakdale for FY26.
Ended Awarded Last action
- Contract number
- 15B51826F00000014
- Awardee
-
Mckesson Corporation UEI S1RUKWWRYFL6 Part of Mckesson Corporation
- Awarding agency
-
Federal Correctional Complex Oakdale
Correctional Facilities, Department of Justice
- Obligated
- $727,616
Award facts
- Contract value 100% obligated
- $727,616.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irving, TX 75039, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $300,000 | |
| Funding Only Action | $14,486 | |
| Funding Only Action | $77,986 | |
| Funding Only Action | $12,549 | |
| Other Administrative Action | $82,223 | |
| Original award | $240,371 |
About this award
McKesson Corporation, a major healthcare services and pharmaceutical distribution company, was awarded a delivery order increase of $300,000 on October 1, 2025, bringing the total contract value to $727,616.35. This delivery order, issued by the Federal Correctional Complex (FCC) Oakdale through the Bureau of Prisons, provides various regular medications for the inmate population at the facility through August 9, 2026. The contract is structured as a firm fixed-price delivery order with no small business set-aside designation and will be performed from McKesson's Irving, Texas location. This award is part of McKesson's extensive federal pharmaceutical distribution portfolio, which includes hundreds of delivery orders to correctional facilities nationwide for controlled and non-controlled medications, specialty pharmaceuticals, and medical supplies supporting Bureau of Prisons healthcare operations.
The Bureau of Prisons relies on McKesson's established pharmaceutical distribution infrastructure to maintain critical medication supply chains across federal correctional institutions. McKesson's federal engagement with the Department of Justice spans multiple facilities including Federal Correctional Institutions, Federal Correctional Complexes, and United States Penitentiaries, with the company serving as a prime contractor on existing indefinite delivery vehicles that streamline procurement of routine medication and medical supply replenishment. The company's substantial federal contract portfolio, operated without set-aside designations reflecting its large business status, demonstrates its critical role as a healthcare infrastructure provider supporting federal correctional and healthcare operations.
Quick answers
Who was awarded contract 15B51826F00000014?
15B51826F00000014 was awarded to Mckesson Corporation by Federal Correctional Complex Oakdale (Correctional Facilities) on October 1, 2025.
How much is contract 15B51826F00000014 worth?
The government has obligated $727,616 on 15B51826F00000014.
Is contract 15B51826F00000014 an order under another contract?
Yes. 15B51826F00000014 is a delivery order under 36W79720D0001, an indefinite delivery contract.
Was contract 15B51826F00000014 competed?
The extent of competition for 15B51826F00000014 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award